CLEARWATER, Fla. — Mercury Medical introduces WoundClot. The new, next generation hemostatic agent.
It expands the use of these agents far beyond present indications: from severe life-threatening penetrating wounds, to a bleeding dialysis fistula, to a simple nosebleed or scalp laceration. Its patented technology is so effective that it will truly change the way clinicians think about hemostatic agents.
The solid gauze converts to an expanding gel and is capable of absorbing over 2,500 percent of its weight in blood. Minimal training is required to effectively use WoundClot.
For more information, contact Mercury Medical at www.mercurymed.com.
About Mercury Medical
For over 50 years, Mercury Medical, a veteran-owned medical products company headquartered in Clearwater, Florida, has been recognized by the industry as a leading provider of innovative airway management devices. For more information, visit www.mercurymed.com or contact Deborah Olson, Director of Marketing at dolson@mercurymed.com.